Azficel-T, sold under the brand name Laviv, is a cell therapy product for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. It consists of fibroblasts harvested from the patient's own skin.It was approved for medical use in the United States in June 2011.

References
Further reading
Smith SR, Munavalli G, Weiss R, et al. (July 2012). "A multicenter, double-blind, placebo-controlled trial of autologous fibroblast therapy for the treatment of nasolabial fold wrinkles". Dermatol Surg. 38 (7 Pt 2): 1234â€“43. doi:10.1111/j.1524-4725.2012.02349.x. PMID 22409385. S2CID 24901992.

External links
"Azficel-T". Drug Information Portal. U.S. National Library of Medicine.
"Laviv (azficel-T)". Medscape. 28 September 2019.
Clinical trial number NCT02120781 for "Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for the Treatment of Vocal Fold Scarring and Age-Related Dysphonia" at ClinicalTrials.gov